首页> 外文期刊>International Journal of Molecular Sciences >MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer
【24h】

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer

机译:MiR-218损害肿瘤的生长并增加对宫颈癌顺铂的化学敏感性

获取原文
           

摘要

MicroRNAs are noncoding RNA molecules of 18–25 nucleotides that regulate gene expression at the post-transcriptional levels. Recent data revealed that miR-218 played key roles in tumor metastasis. Here, we described the regulation and function of miR-218 in cervical cancer. Overexpression of miR-218 reduced the proliferation of the human cervical cancer cell line HeLa and induced cell apoptosis through the AKT-mTOR signaling pathway. In addition, it forced expression of miR-218 suppressed tumor growth in the orthotopic mouse model of HeLa cells. Furthermore, miR-218 increased chemosensitivity to cisplatin (CDDP) in vitro. Our results indicated that targeting miR-218 may provide a strategy for blocking the development of cervical cancer.
机译:MicroRNA是18-25个核苷酸的非编码RNA分子,可在转录后水平调控基因表达。最近的数据显示,miR-218在肿瘤转移中起关键作用。在这里,我们描述了miR-218在宫颈癌中的调控和功能。 miR-218的过表达减少了人宫颈癌HeLa细胞的增殖,并通过AKT-mTOR信号通路诱导了细胞凋亡。此外,它在HeLa细胞原位小鼠模型中强迫miR-218的表达抑制了肿瘤的生长。此外,miR-218在体外增加了对顺铂(CDDP)的化学敏感性。我们的结果表明,靶向miR-218可能提供阻断子宫颈癌发展的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号